kynurenine has been researched along with everolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bossé, D; Braun, D; Bullock, K; Choueiri, TK; Clish, CB; Freeman, GJ; Garraway, LA; Giannakis, M; Gopal, S; Gurjao, C; Horak, C; Jin, C; Lalani, AA; Li, H; McDermott, DF; Schreiber, SL; Sellers, WR; Shukla, SA; Signoretti, S; Stephen Hodi, F; Van Allen, EM; Wind-Rotolo, M | 1 |
1 other study(ies) available for kynurenine and everolimus
Article | Year |
---|---|
Metabolomic adaptations and correlates of survival to immune checkpoint blockade.
Topics: Adaptation, Physiological; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Everolimus; Female; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Kynurenine; Male; Melanoma; Metabolomics; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Treatment Outcome; Tryptophan | 2019 |